Wellbutrin and Qulipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Wellbutrin (bupropion hydrochloride) and Qulipta (atogepant). Common drug interactions include headache among females.

The phase IV clinical study analyzes what interactions people have when they take Wellbutrin and Qulipta. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,107 Wellbutrin users. Check the latest studies of Wellbutrin.

What is Qulipta?

Qulipta has active ingredients of atogepant. eHealthMe is studying from 3,605 Qulipta users. Check the latest studies of Qulipta.

On Jul, 07, 2026

29 people who take Wellbutrin and Qulipta together, and have interactions are studied.

Wellbutrin and Qulipta drug interactions.

What are the common drug interactions of Wellbutrin and Qulipta, by gender? *:

female:

Headache (pain in head)
Fatigue (feeling of tiredness)
Pain
Abdominal pain upper
Asthma
Dehydration (dryness resulting from the removal of water)
Infusion site pain
Sinusitis (inflammation of sinus)
Speech disorder
Migraine (headache)

male:

n/a

What are the common drug interactions of Wellbutrin and Qulipta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Asthma
Cough
Hot flush (sudden feelings of heat)
Hyperhidrosis (abnormally increased sweating)
Intermenstrual bleeding
Migraine (headache)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

20-29:

Constipation
Injection site urticaria (rash of round, red welts on the skin at injection site)
Suicidal ideation

30-39:

Throat tightness
Upper-airway cough syndrome
Varicose vein (veins that have become enlarged and tortuous)
Weight decreased
Pain
Abdominal discomfort
Abdominal pain
Abdominal pain upper
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Butterfly rash

40-49:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Speech disorder
Asthma
Fatigue (feeling of tiredness)
Fungal infection
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)

50-59:

Nausea (feeling of having an urge to vomit)
Constipation
Dry mouth
Abdominal pain
Chills (felling of cold)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pyrexia (fever)
Rash

60+:

Coronavirus test positive
Decreased appetite
Infection
Infusion site pain
Lymphoma (cancer that begins in immune system cells)
Malaise (a feeling of general discomfort or uneasiness)
Mass
Oral infection
Oral pain
Oral viral infection

What are the existing conditions these people have? *

Migraine (headache): 14 people, 48.28%
Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 17.24%
Stress And Anxiety: 4 people, 13.79%
Spondyloarthropathy (any joint disease of the vertebral column): 3 people, 10.34%
Immunodeficiency Common Variable: 3 people, 10.34%
Pain: 2 people, 6.90%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.90%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 6.90%
Drowsiness: 2 people, 6.90%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and Qulipta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously